Res. Asst. PhD Ceren TİLGEN YASASEVER

Metrics

Publication

Citation (WoS)

139

H-Index (WoS)

Citation (Scopus)

160

H-Index (Scopus)

Project

UN Sustainable Development Goals

Education Information

2014 - 2022

Doctorate

Istanbul University, Onkoloji Enstitüsü, Kanser Biyokimyası Bilim Dalı, Turkey

2011 - 2014

Postgraduate

Istanbul University, Onkoloji Enstitüsü, Kanser Biyokimyası Bilim Dalı, Turkey

2008 - 2010

Postgraduate

Ankara University, Fen Fakültesi, Zooloji, Turkey

2003 - 2008

Undergraduate

Ankara University, Fen Fakültesi, Biyoloji, Turkey

Research Areas

Medicine

Health Sciences

Fundamental Medical Sciences

Biochemistry

Internal Medicine Sciences

Chemistry

Biochemistry

Natural Sciences

Academic Titles / Tasks

2014 - Continues

Research Assistant

Istanbul University, Onkoloji Enstitüsü, Temel Onkoloji Ana Bilim Dalı

Published journal articles indexed by SCI, SSCI, and AHCI

2019

Diagnostic and Prognostic Significance of Carboxypeptidase A4 (CPA4) in Breast Cancer

Bademler S., Ucuncu M. Z., Yasasever C., Serilmez M., Ertin H., Karanlik H.

BIOMOLECULES , vol.9, no.3, 2019 (SCI-Expanded)

2019

ROLE OF INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-3 (IGFBP-3) IN THE DIAGNOSIS OF PANCREATIC ADENOCARCINOMA AND MONITORING TREATMENT RESPONSE

Bademler S., Ucuncu W. Z., Sari M., Yasasever C., Afsar C. U., Tastekin D.

ACTA MEDICA MEDITERRANEA , vol.35, no.1, pp.71-75, 2019 (SCI-Expanded)

2019

IGF-1 AND IGFBP-3 IN COLORECTAL CANCER, AN OBSERVATIONAL CASE-CONTROL STUDY

Bademler S., ZİRTİLOĞLU A., Sari M., Yasasever C., Karabulut S.

ACTA MEDICA MEDITERRANEA , vol.35, no.1, pp.15-21, 2019 (SCI-Expanded)

2018

Can DCLK1 be a biomarker for head and neck cancer?

Yasasever C., Dogru E., Serilmez M., Ahmet K., Karaman S.

FEBS OPEN BIO , vol.8, pp.318, 2018 (SCI-Expanded)

2016

Clinical significance of serum caveolin-1 levels in melanoma patients

Tas F., Karabulut S., Yasasever C. T., Duranyildiz D.

INTERNATIONAL JOURNAL OF DERMATOLOGY , vol.55, no.5, pp.558-562, 2016 (SCI-Expanded)

2015

Clinical significance of serum interleukin-18 (IL-18) levels in patients with gastric cancer

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

BIOMEDICINE & PHARMACOTHERAPY , vol.70, pp.19-23, 2015 (SCI-Expanded)

2015

Serum transforming growth factor-beta1 levels may have predictive and prognostic roles in patients with gastric cancer.

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.36, no.3, pp.2097-103, 2015 (SCI-Expanded)

2015

Circulating annexin A2 as a biomarker in gastric cancer patients: Correlation with clinical variables

Tas F., Yasasever C. T., Karabulut S., Tastekin D., Duranyildiz D.

Biomedicine and Pharmacotherapy , vol.69, pp.237-241, 2015 (SCI-Expanded)

2014

The diagnostic, predictive, and prognostic role of serum epithelial cell adhesion molecule (EpCAM) and vascular cell adhesion molecule-1 (VCAM-1) levels in breast cancer

Karabulut S., Tas F., Tastekin D., KARABULUT M., Yasasever C., Ciftci R., et al.

TUMOR BIOLOGY , vol.35, no.9, pp.8849-8860, 2014 (SCI-Expanded)

2014

Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma

Tas F., Karabulut S., Yasasever C., Duranyildiz D.

TUMOR BIOLOGY , vol.35, no.7, pp.7233-7237, 2014 (SCI-Expanded)

2014

Is there any diagnostic value of serum protease-activated receptor-1 (PAR1) levels on determination of epithelial ovarian carcinoma?

Karabulut S., Aksit E., Tas F., Ciftci R., Aydiner A., Yildiz I., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , vol.35, no.5, pp.4323-9, 2014 (SCI-Expanded)

2014

Clinical significance of serum circulating insulin-like growth factor-1 (IGF-1) mRNA in hepatocellular carcinoma

Karabulut S., Duranyildiz D., Tas F., Gezer U., Akyuz F., Serilmez M., et al.

TUMOR BIOLOGY , vol.35, no.3, pp.2729-2739, 2014 (SCI-Expanded)

2014

High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer

Ciftci R., Tas F., Yasasever C., Aksit E., Karabulut S., Sen F., et al.

Tumor Biology , vol.35, no.7, pp.6941-6948, 2014 (SCI-Expanded)

2013

For Which Cancer Types can Neuron-Specific Enolase be Clinically Helpful in Turkish Patients?

Bilgin E., Dizdar Y., Serilmez M., Soydinc H. O., Yasasever C., Duranyildiz D., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.4, pp.2541-2544, 2013 (SCI-Expanded)

2012

Markers of Bone Metastases in Breast and Lung Cancers

Bilgin E., Yasasever V., Soydinc H. O., Yasasever C., Ozturk N., Duranyildiz D.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.9, pp.4331-4334, 2012 (SCI-Expanded)

Articles Published in Other Journals

2016

Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma

KARABULUT S., Afsar Ç. U., Karabulut M., Alış H., Kılıc L., Çikot M., et al.

Journal of Gastrointestinal Cancer , vol.47, no.1, pp.47-54, 2016 (Scopus)

Refereed Congress / Symposium Publications in Proceedings

2018

Tensin-2 Molekülünün Meme Kanserli Hastalardaki Önemi

YASASEVER C. T., BILGIN E., SERİLMEZ M., OĞUZ SOYDİNÇ H., BADEMLER S., KARANLIK H., et al.

29. Ulusal Biyokimya Kongresi, Muğla, Turkey, 26 - 30 October 2018, pp.1

2017

Importance of AXL Molecule in Lung Cancers

Kizir A., Bilgin Doğru E., Tilgen Yasasever C., Serilmez M.

15. İstanbul Üniversitesi Onkoloji Enstitüsü Günleri Sempozyumu ve 8. İstanbul Üniversitesi Onkoloji Enstitüsü Çalıştayı, İstanbul, Turkey, 1 - 02 December 2017, pp.1

2017

Meme Kanseri Tanılı Hastalarda 25(OH)D Vitamini Düzeyleri

Hatiboğlu S., BİLGİN DOĞRU E., TİLGEN YASASEVER C., SALMAYENLİ N.

Uluslararası Katılımlı Kongre & LAB Expo 2017, Antalya, Turkey, 1 - 05 October 2017, pp.95

2017

Meme Kanserli Hastalarda TIMP-1, HA ve SPARC Düzeyleri

Tilgen Yasasever C., Bilgin Doğru E., Serilmez M., Öztürk N., Yasasever F. V.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.162

2017

Over Kanserinde HMGB1 ve IRE1'in Önemi

BİLGİN DOĞRU E., TİLGEN YASASEVER C., SERİLMEZ M., SAİP P. M., YASASEVER F. V.

22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.159

2017

Serum caveolin-1 and fibronectin levels as clinical markers for patients with malignant melanoma

Yasasever C., Dogru E., Serilmez M., Tas F., Yasasever V.

ECCO European Cancer Congress, Amsterdam, Netherlands, 27 - 30 January 2017, vol.72

2017

Clinical significance of caveolin-1 and fibronectin in pancreatic cancer

Dogru E., Yasasever C., Serilmez M., Dagoglu N., Yasasever V.

ECCO European Cancer Congress, Amsterdam, Netherlands, 27 - 30 January 2017, vol.72

2017

The biological role of AKT serine/threonine kinase 2 in lung cancer

Serilmez M., Karaman S., Soydinc H. O., Yasasever C., Bilgin E., Duranyildiz D., et al.

ECCO European Cancer Congress, Amsterdam, Netherlands, 27 - 30 January 2017, vol.72

2015

Importance of HGMB1 serum levels in breast cancer patients

Yasasever V., Serilmez M., Yasasever C., Ciftci R.

40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life, Berlin, Germany, 4 - 09 July 2015, vol.282, pp.262

2015

Clinical significance of serum vascular cell adhesion molecule-1(VCAM-1) in colorectal cancer

Ciftci R., Aykan N. F., Aksit E., YASASEVER C. T., Vatansever S., Yasasever V.

Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 15 - 17 January 2015, vol.33

2014

SERUM TIMP-1 LEVELS IN MALIGNANT MELANOMA PATIENTS

TİLGEN YASASEVER C., Aksit E., Duranyildiz D., Tas F., YASASEVER F. V.

IFCC WorldLab, İstanbul, Turkey, 22 - 26 June 2014, pp.475

2014

THE IMPORTANCE OF CEA IN COLON CANCER

Aksit E., TİLGEN YASASEVER C., ÖZTÜRK N., DURANYILDIZ H. D., YASASEVER F. V.

IFCC WorldLab, İstanbul, Turkey, 22 - 26 June 2014, pp.363

2014

Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.

CIFTCI R., Tas F., AKSIT E., Vatansever S., KARABULUT S., Sen F., et al.

50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32

2014

Akciğer Karsinomlu Hatalarda VCAM-1 ve EPCAM Serum Konsantrasyonlarının Klinik Önemi

Tastekin D., Karabulut S., TAŞ F., Ciftci R., TİLGEN YASASEVER C., DURANYILDIZ H. D.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.572

2014

Meme Kanserli Hastalarda Serum Par-1 (Protease Activated Receptor-1) Düzeylerinin Klinik Açıdan Önemi

Ciftci R., Karabulut S., Aksit E., TAŞ F., TİLGEN YASASEVER C., VATANSEVER S., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.500

2014

Serum Transforme Edici Büyüme Faktörü-Beta1 (TGF-B1) Seviyelerinin Epitelyal Over Kanserli Hastalarda Klinik Önemi

Karabulut S., Ciftci R., Tastekin D., VATANSEVER S., TAŞ F., TİLGEN YASASEVER C., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.421

2014

Meme Kanserli Hstalarda Serum MIF (Macrophage Migration Inhibitory Factor) Düzeylerinin Klinik Açıdan Önemi

Ciftci R., Karabulut S., TİLGEN YASASEVER C., Aksit E., Yildiz I., BİLGİN DOĞRU E., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.501

2014

Serum Hücresel Adhezyon Molekülleri (VCAM-1, EPCAM) Seviyelerinin Meme Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü

Karabulut S., Ciftci R., Tastekin D., VATANSEVER S., Aydiner A., TİLGEN YASASEVER C., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.493

2014

Epitelya Over Kanserli Hastalarda Serum İnsulin-Like Growth Factor (IGF-1) ve İnSulin- Like Growth Factor Binding Protein-3'ün Klinik Önemi

Tastekin D., Karabulut S., Tas F., Ciftci R., TİLGEN YASASEVER C., DURANYILDIZ H. D.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.571

2014

Epitelyal Over Kanserli Hastalarda Yüksek Serum Epidermal Büyüme Faktör Reseptörü (EGFR) Düzeyleri Kötü Progresyonsuz Sağkalımla İlişkilidir

Karabulut S., Ciftci R., Tastekin D., TİLGEN YASASEVER C., VATANSEVER S., Duranyildiz D., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.428

2014

Epitelyal Over Kanserinin Belirlenmesi Üzerinde Protease Activated Receptor-1(PAR-1) Düzeylerinin Herhangi Bir Tanısal Değeri Var Mıdır?

Karabulut S., Ciftci R., Vatansever S., TAŞ F., TİLGEN YASASEVER C., YASASEVER F. V., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.421

2014

Serum Makrofaj Migrasyon İnhibitör Faktörü (MIF) Düzeylerinin Epitelyal Over Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü

Karabulut S., Ciftci R., Tastekin D., Vatansever S., Keskin S., Yildiz I., et al.

5. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 19 - 23 March 2014, pp.420

2012

Leptin levels in breast cancer

Serilmez M., Soydinc H. O., Bilgin E., Yasasever C., Duranyildiz D.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.101-102

2012

Significance of NSE in various cancer types

Bilgin E., Soydinc H. O., Yasasever C. T., Serilmez M., Yasasever V.

22nd IUBMB Congress/37th FEBS Congress, Sevilla, Spain, 4 - 09 September 2012, vol.279, pp.101

2011

İleri evre kolon kanserli hastalarda serum adiponektin düzeyleri

serilmez m., BİLGİN DOĞRU E., TİLGEN YASASEVER C., Duranyildiz D., YASASEVER F. V.

3. DETAE Günleri, İstanbul, Turkey, 17 - 18 November 2011, pp.74

Supported Projects

2018 - Continues

Melanom Dışı Deri Kanserli Hastalarda SERPIN B1 ve SERPIN B13 Düzeyleri

Project Supported by Higher Education Institutions

DAĞOĞLU SAKİN R. N. (Executive), ORAL E. N., TİLGEN YASASEVER C., BİLGİN DOĞRU E., KARAMAN Ş., SERİLMEZ M.

2018 - Continues

Meme Kanserli Hastaların Kan ve Tükürük Örneklerinde Cullin7 Seviyesinin Araştırılması

Project Supported by Higher Education Institutions

DURANYILDIZ H. D. (Executive), TİLGEN YASASEVER C.

2017 - 2019

Meme Tümörlerinde Nektin2 ve Nektin4 Adezyon Molekülleri

Project Supported by Higher Education Institutions

VATANSEVER S. (Executive), BADEMLER S., TİLGEN YASASEVER C., KARANLIK H., SERİLMEZ M., BİLGİN DOĞRU E.

2017 - 2018

Meme Tümörlerinde Tensin2 Molekülü

Project Supported by Higher Education Institutions

KARANLIK H. (Executive), TİLGEN YASASEVER C., SERİLMEZ M., BİLGİN DOĞRU E., BADEMLER S., OĞUZ SOYDİNÇ H.

2017 - 2018

Akciğer Kanserlerinde AXL Molekülü

Project Supported by Higher Education Institutions

KİZİR A. (Executive), SERİLMEZ M., BİLGİN DOĞRU E., TİLGEN YASASEVER C., ERTÜRK K.

2017 - 2018

Baş-Boyun Kanserlerinde DCLK1 Molekülü

Project Supported by Higher Education Institutions

KARADENİZ A. N. (Executive), SERİLMEZ M., KARAMAN Ş., TİLGEN YASASEVER C., BİLGİN DOĞRU E.

2017 - 2018

Meme Kanserinde CPA4 Seviyesinin Belirlenmesi ve Önemi

Project Supported by Higher Education Institutions

BADEMLER S. (Executive), SERİLMEZ M., BİLGİN DOĞRU E., KARANLIK H., TİLGEN YASASEVER C.

Scientific Refereeing

July 2023

CANCER BIOMARKERS

SCI Journal

May 2023

CANCER BIOMARKERS

SCI Journal

March 2023

CANCER BIOMARKERS

SCI Journal

January 2023

CANCER BIOMARKERS

SCI Journal

November 2022

BMC CANCER

SCI Journal

Congress and Symposium Activities

22 June 2023 - 22 June 2023

Temel Onkoloji Derneği ve Sistem Biyolojisi ve Biyoinformatik Derneği İşbirliği ve İ.Ü. Onkoloji Enstitüsünün Katkıları ile “İşbirliği Toplantıları-V” Toplantısı

Audience

İstanbul-Turkey

21 May 2023 - 25 May 2023

XXV IFCC-EFLM EuroMedLab Congress

Audience

Rome-Italy

07 April 2023 - 07 April 2023

Ulusal Kanser Haftası Farkındalığı Arttırma Sempozyumu

Audience

İstanbul-Turkey

20 January 2023 - 20 January 2023

İ.Ü. Onkoloji Enstitüsü Günleri

Audience

İstanbul-Turkey

16 September 2021 - 18 September 2021

3rd International Cancer and Ion Channels Congress

Audience

İstanbul-Turkey

15 February 2021 - 17 February 2021

Critical Role of Clinical Laboratories in the Covid-19 Pandemic

Audience

Milan-Italy

19 December 2020 - 19 December 2020

18. İSTANBUL ÜNİVERSİTESİ ONKOLOJİ ENSTİTÜSÜ GÜNLERİ

Audience

İstanbul-Turkey

18 December 2020 - 19 December 2020

16. Ulusal Onkolojik Araştırmalar Web Çalıştayı

Audience

İstanbul-Turkey

09 December 2020 - 09 December 2020

TEOD Bilim Günü

Audience

İstanbul-Turkey

01 October 2018 - 01 October 2018

TBD ULUSLARARASI BİYOKİMYA KONGRESİ 2018, 29. ULUSAL BİYOKİMYA KONGRESİ

Attendee

Muğla-Turkey

01 September 2018 - 01 September 2018

ARAŞTIRMADA VE TIBBİ UYGULAMADA KULLANILAN MOLEKÜLER LABORATUVAR TEKNİKLERİ UYGULAMALI EĞİTİM KURSU

Attendee

Ankara-Turkey

01 July 2018 - 01 July 2018

THE 43rd FEBS CONGRESS

Attendee

Praha-Czech Republic

01 October 2017 - 01 October 2017

KONGRE&LAB EXPO 2017

Attendee

Antalya-Turkey

01 April 2017 - 01 April 2017

22. ULUSAL KANSER KONGRESİ

Attendee

Antalya-Turkey

01 January 2017 - 01 January 2017

EUROPEAN CANCER CONGRESS ECCO 2017

Attendee

Amsterdam-Netherlands

01 April 2015 - 01 April 2015

21. ULUSAL KANSER KONGRESİ

Attendee

Antalya-Turkey

01 December 2014 - 01 December 2014

Türk Tıbbi Onkoloji Kongresi

Attendee

-Turkey

01 October 2014 - 01 October 2014

Karaköy Otofaji Sempozyumu

Attendee

-Turkey

01 September 2014 - 01 September 2014

1. Moleküler Üroloji Toplantısı

Attendee

-Turkey

01 June 2014 - 01 June 2014

IFCC WorldLab İstanbul

Attendee

-Turkey

01 September 2012 - 01 September 2012

FEBS Congress

Attendee

-Spain

01 November 2011 - 01 November 2011